Published in Clin Rheumatol on June 25, 2005
Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report. Rheumatol Int (2010) 2.00
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol (2009) 1.51
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study. Arthritis Res Ther (2006) 1.13
Deforming arthropathy in SLE: review in the literature apropos of one case. Rheumatol Int (2008) 0.90
Rhupus arthropathy as the presenting manifestation in Juvenile SLE: a case report. Pediatr Rheumatol Online J (2007) 0.86
RHUPUS Syndrome in Children: A Case Series and Literature Review. Case Rep Rheumatol (2013) 0.84
Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study. Medicine (Baltimore) (2014) 0.81
Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients. Clin Rheumatol (2015) 0.79
Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus. J Clin Immunol (2010) 0.79
Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts. Arthritis Res Ther (2016) 0.79
Ultrasonography is useful to detect subclinical synovitis in SLE patients without musculoskeletal involvement before symptoms appear. Clin Rheumatol (2014) 0.76
Silicone-induced foreign-body reaction after first metatarsophalangeal joint arthroplasty for Jaccoud's arthropathy. Rheumatol Int (2008) 0.75
Rhupus; unusual presentations. Clin Rheumatol (2015) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1993) 2.88
Coexistence of systemic lupus erythematosus and rheumatoid arthritis. Report of a case and review of the literature, with clinical, pathologic and serologic observations. Am J Med (1969) 1.73
Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis (1998) 1.55
'Rhupus' syndrome. Arch Intern Med (1988) 1.46
Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (2001) 1.34
Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum (1991) 1.30
Clinical and immunogenetic characterization of Mexican patients with 'rhupus'. Lupus (2002) 1.13
Deforming arthropathy of the hands in systemic lupus erythematosus. J Rheumatol (1988) 1.12
Erosive arthritis in systemic lupus erythematosus: analysis of a distinct clinical and serological subset. Br J Rheumatol (1998) 1.06
Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis (1987) 0.98
Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. Ann Rheum Dis (1992) 0.91
One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) (1995) 0.90
The L.E. cell in rheumatoid arthritis. Am J Med Sci (1960) 0.90
"Rheumatoid" nodules in systemic lupus erythematosus. Ann Intern Med (1970) 0.89
Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol (1978) 0.87
Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. J Rheumatol (1992) 0.79
The coexistence of rheumatoid arthritis and systemic lupus erythematosus: a case report and review of the literature. J Rheumatol (1981) 0.78
[Clinical and serological manifestations of 307 Spanish patients with systemic lupus erythematosus. Comparison with other ethnic groups]. Rev Clin Esp (1995) 0.76
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 12.07
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum (2006) 3.64
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum (2011) 3.60
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis (2012) 3.47
Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum (2003) 3.35
Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol (2009) 3.10
Wegener's granulomatosis. Lancet (2006) 2.83
Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum (2003) 2.62
No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum (2004) 2.48
Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol (2007) 2.33
Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum (2011) 2.31
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum (2012) 2.25
Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol (2004) 2.25
Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med (2007) 2.17
Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 2.08
Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum (2008) 2.02
Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol (2002) 2.01
Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol (2009) 2.01
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum (2011) 1.91
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum (2005) 1.88
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J Clin Invest (2003) 1.87
Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment. Arthritis Rheum (2003) 1.83
Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.79
Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol (2012) 1.69
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum (2010) 1.67
Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc (2006) 1.64
Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol (2012) 1.62
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest (2003) 1.59
Interstitial lung disease in primary Sjögren syndrome. Chest (2006) 1.55
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol (2009) 1.51
Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford) (2014) 1.49
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood (2008) 1.49
Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum (2009) 1.47
Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol (2012) 1.46
All medical eponyms should be abandoned. Presse Med (2007) 1.45
Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis (2009) 1.40
Need for circumspection in prescribing tumor necrosis factor inhibitors and other biologic response modifiers. Arthritis Rheum (2002) 1.39
Mitral valve repair is durable in patients with rheumatoid arthritis. Ann Thorac Surg (2012) 1.39
Eponyms: what's in a name? Retina (2010) 1.39
Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members. Physiol Genomics (2006) 1.34
Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34
Lung disease in rheumatoid arthritis. Curr Opin Rheumatol (2008) 1.33
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis (2011) 1.33
Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol (2006) 1.32
Renal involvement in primary Sjögren's syndrome: a clinicopathologic study. Clin J Am Soc Nephrol (2009) 1.31
Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 1.30
A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis. J Rheumatol (2002) 1.30
Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality. J Rheumatol (2012) 1.29
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J Rheumatol (2005) 1.28
The future of damage assessment in vasculitis. J Rheumatol (2007) 1.27
The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford) (2010) 1.24
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis (2012) 1.23
Polymyalgia rheumatica. BMJ (2008) 1.22
Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum (2003) 1.19
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther (2005) 1.17
Cardiovascular co-morbidity in rheumatic diseases. Vasc Health Risk Manag (2008) 1.16
The diagnostic challenges presented by patients with medically unexplained symptoms in general practice. Scand J Prim Health Care (2008) 1.15
Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14
Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol (2011) 1.12
Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford) (2012) 1.12
Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc (2013) 1.11
Cogan's syndrome: an audiovestibular, ocular, and systemic autoimmune disease. Rheum Dis Clin North Am (2007) 1.10
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther (2008) 1.08
Incidence of spondyloarthropathy in patients with Crohn's disease: a population-based study. J Rheumatol (2012) 1.06
A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Psychol Med (2006) 1.06
Genetics of rheumatoid arthritis. Mayo Clin Proc (2006) 1.05
Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Ophthalmol (2011) 1.05
Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol (2010) 1.04
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials. Arthritis Care Res (Hoboken) (2013) 1.03
Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis Rheum (2012) 1.03
Targeting physical activity promotion in general practice: characteristics of inactive patients and willingness to change. BMC Public Health (2008) 1.03
Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum (2006) 1.02
My treatment approach to rheumatoid arthritis. Mayo Clin Proc (2012) 1.02
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis (2010) 1.01
Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient! Arthritis Rheum (2006) 1.01
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.01
Rheumatoid vasculitis: an update. Curr Opin Rheumatol (2015) 1.01
Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clin Rheumatol (2004) 1.00
CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthritis Rheum (2007) 1.00
Commercial bee pollen with different geographical origins: a comprehensive approach. Int J Mol Sci (2012) 0.99
Hearing loss in rheumatoid arthritis. Laryngoscope (2006) 0.98
Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol (2010) 0.98
Statin use in giant cell arteritis: a retrospective study. J Rheumatol (2013) 0.98
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. J Am Soc Nephrol (2011) 0.98
Characterization of artisanal honey produced on the Northwest of Portugal by melissopalynological and physico-chemical data. Food Chem Toxicol (2010) 0.97
Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol (2011) 0.97
Primer: Demystifying risk--understanding and communicating medical risks. Nat Clin Pract Rheumatol (2007) 0.95
Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol (2009) 0.95